ID
32066
Description
Study ID: 103992 Clinical Study ID: 103992 Study Title: Evaluate immunogenicity, reactogenicity & safety of 2 doses of GSK Biologicals’ oral live attenuated HRV vaccine (RIX4414 at 106.5 CCID50) when given concomitantly with OPV versus given alone (HRV vaccine dose given 15 days after the OPV dose) in healthy infants in Bangladesh Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00139334 https://clinicaltrials.gov/ct2/show/NCT00139334 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Rotavirus Vaccine Trade Name: Rotarix Study Indication: Haemophilus influenzae type b; Neisseria Meningitidis This form is for documentation of study continuation and reasons for non continuation. To be checked at each visit from visit 2 onward. Visit 2 -> Timing: Day 30, Age: 10 weeks +/- 1 week (one item less) Visit 3 -> Timing: Day 45, Age: 12 weeks +/- 1 week Visit 4 -> Timing: Day 60, Age: 14 weeks +/- 1 week Visit 5 -> Timing: Day 75, Age: 16 weeks +/- 1 week Visit 6 -> Timing: Day 105, Age: 20 weeks +/- 1 week
Link
https://clinicaltrials.gov/ct2/show/NCT00139334
Keywords
Versions (1)
- 10/16/18 10/16/18 - Sarah Riepenhausen
Copyright Holder
GlaxoSmithKline
Uploaded on
October 16, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
GSK Biologicals' oral HRV vaccine given with OPV in infants NCT00139334
Study Continuation
- StudyEvent: ODM
Description
Check for study continuation
Alias
- UMLS CUI-1
- C0805733
- UMLS CUI-2
- C0008976
- UMLS CUI-3
- C0042210
Description
if yes: please complete all necessary forms for this visit. if no: please complete the rest of the items of this form.
Data type
boolean
Alias
- UMLS CUI [1]
- C0805733
Description
if yes, you can skip the following item. This is only applicable from Visit 3 onward (not applicable for visit 2).
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0457454
- UMLS CUI [1,2]
- C0566251
Description
Reason for discontinuation
Data type
text
Alias
- UMLS CUI [1,1]
- C0457454
- UMLS CUI [1,2]
- C0566251
Description
If the most appropriate reason for discontinuation is a serious adverse event, please specify SAE No. and complete SAE form.
Data type
text
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C0237753
Description
If the most appropriate reason for discontinuation is a non-serious adverse event (unsolicited), please specify unsolicited AE No. and complete Non-serious Adverse Event form. If solicited AE, please complete the solicited adverse event code item instead.
Data type
integer
Alias
- UMLS CUI [1,1]
- C4055646
- UMLS CUI [1,2]
- C1518404
- UMLS CUI [1,3]
- C0237753
Description
If the most appropriate reason for discontinuation is a non-serious adverse event (solicited), please specify solicited AE code and complete solicited Non-serious Adverse Event form. If unsolicited non-serious adverse event, please complete the Unsoliceted AE number item.
Data type
integer
Alias
- UMLS CUI [1,1]
- C1517001
- UMLS CUI [1,2]
- C1518404
- UMLS CUI [1,3]
- C0237753
Description
If the reason is not an adverse event, please specify, e.g. consent withdrawal protocol violation, ...
Data type
text
Alias
- UMLS CUI [1]
- C3840932
Description
Person deciding about discontinuation
Data type
text
Alias
- UMLS CUI [1,1]
- C0679006
- UMLS CUI [1,2]
- C0457454
Similar models
Study Continuation
- StudyEvent: ODM
C0008976 (UMLS CUI-2)
C0042210 (UMLS CUI-3)
C0566251 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,3])
C1518404 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,3])
C0457454 (UMLS CUI [1,2])